Gulhane Sushma Rajesh, Kotwal M N
Department of Pathology, ESI-PGIMSR and Model Hospital, Andheri, Mumbai, India.
Government Medical College, Nagpur, Maharashtra, India.
Indian J Dermatol. 2015 Sep-Oct;60(5):523. doi: 10.4103/0019-5154.164443.
Neurofibromatosis type 1 (NF1) represents a major risk factor for development of malignancies, particularly malignant peripheral nerve sheath tumors (MPNST), optic gliomas, other gliomas, and leukemia. We report an unusual case of chronic myeloid leukemia (CML), developed in a patient of NF1. A 40-year-old Indian male, clinically manifesting NF1 since his childhood, presented with huge splenomegaly. Patient also had a large tumor mass arising in a café-au-lait spot on lower back with rapid growth in last 6 months. Excision of this tumor was done, and it turned out to be a diffuse neurofibroma histologically. Peripheral smear was also done in view of splenomegaly, which showed features of chronic myeloid leukemia. CML rarely co-exists with NF1, and there are a very few reports of such cases. It is important to be aware of the possibility that not only the malignant change in benign PNST is more common in these patients, but also other malignancies like CNS tumors and hematolymphoid neoplasm do occur with increased frequency.
1型神经纤维瘤病(NF1)是发生恶性肿瘤的主要危险因素,尤其是恶性外周神经鞘瘤(MPNST)、视神经胶质瘤、其他胶质瘤和白血病。我们报告了1例NF1患者发生慢性髓系白血病(CML)的罕见病例。一名40岁的印度男性,自幼临床诊断为NF1,就诊时出现巨大脾脏肿大。患者下背部一个咖啡牛奶斑处还出现了一个大肿块,在过去6个月内迅速生长。对该肿瘤进行了切除,组织学检查显示为弥漫性神经纤维瘤。鉴于脾脏肿大,还进行了外周血涂片检查,结果显示为慢性髓系白血病特征。CML很少与NF1共存,此类病例的报道非常少。重要的是要意识到,这些患者不仅良性外周神经鞘瘤的恶变更为常见,而且中枢神经系统肿瘤和血液淋巴系统肿瘤等其他恶性肿瘤的发生频率也会增加。